review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0924-8579(02)00295-9 |
P698 | PubMed publication ID | 12615379 |
P50 | author | Ziad A Memish | Q76089502 |
P2093 | author name string | Hanan H Balkhy | |
P2860 | cites work | Comparative efficacy of insect repellents against mosquito bites | Q28208947 |
Viral hemorrhagic fever hazards for travelers in Africa | Q34398543 | ||
An outbreak of Rift Valley fever in Northeastern Kenya, 1997-98. | Q37320063 | ||
Climate-disease connections: Rift Valley Fever in Kenya. | Q38456912 | ||
Recurrence of Rift Valley fever in Egypt | Q38880763 | ||
The Rift Valley fever epizootic in Egypt 1977–1978 2. Ecological and entomological studies | Q39076413 | ||
Rift Valley fever, Egypt 1977: disease spread by windborne insect vectors? | Q39445205 | ||
Quantitative real-time PCR detection of Rift Valley fever virus and its application to evaluation of antiviral compounds | Q39467349 | ||
Rift Valley fever virus ecology and the epidemiology of disease emergence | Q40581805 | ||
First isolation of the Rift Valley fever virus from Culex poicilipes (Diptera: Culicidae) in nature | Q40604475 | ||
Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience. | Q40632227 | ||
Rift valley fever surveillance in the lower Senegal river basin: update 10 years after the epidemic | Q40632284 | ||
Rift Valley fever in Nigeria: infections in humans. | Q40663886 | ||
Rift Valley fever in rural northern Senegal: human risk factors and potential vectors. | Q40700580 | ||
Repelling mosquitoes | Q44148320 | ||
Spread of Rift Valley fever virus from continental Africa | Q45894467 | ||
P433 | issue | 2 | |
P921 | main subject | zoonosis | Q182672 |
Rift Valley fever | Q326638 | ||
Rift Valley fever phlebovirus | Q24809101 | ||
P304 | page(s) | 153-157 | |
P577 | publication date | 2003-02-01 | |
P1433 | published in | International Journal of Antimicrobial Agents | Q15724616 |
P1476 | title | Rift Valley fever: an uninvited zoonosis in the Arabian peninsula | |
P478 | volume | 21 |
Q42218824 | A One Health approach to the control of zoonotic vectorborne pathogens |
Q28647232 | A Spatial Analysis of Rift Valley Fever Virus Seropositivity in Domestic Ruminants in Tanzania |
Q40379142 | A complex adenovirus-vectored vaccine against Rift Valley fever virus protects mice against lethal infection in the presence of preexisting vector immunity |
Q43046864 | A glycerophospholipid-specific pocket in the RVFV class II fusion protein drives target membrane insertion. |
Q40197590 | A modeling approach to investigate epizootic outbreaks and enzootic maintenance of Rift Valley fever virus |
Q37561593 | A need for One Health approach - lessons learned from outbreaks of Rift Valley fever in Saudi Arabia and Sudan |
Q98465932 | A protective bivalent vaccine against Rift Valley fever and bluetongue |
Q58757705 | A quantitative exploration of nomadic pastoralists' knowledge and practices towards Rift Valley fever in Niger State, North-central Nigeria: The associated socio-cultural drivers |
Q33621078 | A replication-incompetent Rift Valley fever vaccine: chimeric virus-like particles protect mice and rats against lethal challenge |
Q34487937 | A systematic review of Rift Valley Fever epidemiology 1931-2014. |
Q36414218 | Acid-activated structural reorganization of the Rift Valley fever virus Gc fusion protein |
Q64114488 | An Overview of the Most Significant Zoonotic Viral Pathogens Transmitted from Animal to Human in Saudi Arabia |
Q40043424 | An equine herpesvirus type 1 (EHV-1) vector expressing Rift Valley fever virus (RVFV) Gn and Gc induces neutralizing antibodies in sheep |
Q24701804 | Apoptosis, autophagy and unfolded protein response pathways in Arbovirus replication and pathogenesis |
Q35778817 | Arboviral encephalitides: transmission, emergence, and pathogenesis |
Q35083136 | Assessment of research productivity of Arab countries in the field of infectious diseases using Web of Science database |
Q38613824 | Bunyaviruses and the type I interferon system |
Q37087027 | Characterisation of immune responses and protective efficacy in mice after immunisation with Rift Valley Fever virus cDNA constructs |
Q38328619 | Characterization of RNA aptamers directed against the nucleocapsid protein of Rift Valley fever virus. |
Q40448667 | Characterization of Rift Valley fever virus transcriptional terminations. |
Q47159695 | Climate change and water management in the biblical city of Dan. |
Q33796551 | Comparative production analysis of three phlebovirus nucleoproteins under denaturing or non-denaturing conditions for crystallographic studies |
Q35797105 | Comparison of Rift Valley fever virus replication in North American livestock and wildlife cell lines |
Q33705717 | Countermeasure development for Rift Valley fever: deletion, modification or targeting of major virulence factor NSs |
Q26315243 | Detection of Sindbis and Inkoo Virus RNA in Genetically Typed Mosquito Larvae Sampled in Northern Sweden |
Q35126733 | Development of a novel, single-cycle replicable rift valley Fever vaccine |
Q40123495 | Development of a sheep challenge model for Rift Valley fever. |
Q36559849 | Dicer-2- and Piwi-mediated RNA interference in Rift Valley fever virus-infected mosquito cells |
Q35107614 | Dual functions of Rift Valley fever virus NSs protein: inhibition of host mRNA transcription and post-transcriptional downregulation of protein kinase PKR. |
Q34770212 | Ecological niche modeling and land cover risk areas for rift valley fever vector, culex tritaeniorhynchus giles in Jazan, Saudi Arabia. |
Q50329180 | Efficacy of different DNA and MVA prime-boost vaccination regimens against a Rift Valley fever virus (RVFV) challenge in sheep 12 weeks following vaccination |
Q39893246 | Efficient production of Rift Valley fever virus-like particles: The antiviral protein MxA can inhibit primary transcription of bunyaviruses |
Q40397884 | Electron cryo-microscopy and single-particle averaging of Rift Valley fever virus: evidence for GN-GC glycoprotein heterodimers |
Q33845578 | Emergence of zoonotic arboviruses by animal trade and migration |
Q89967836 | Emerging Threats to Animals in the United Kingdom by Arthropod-Borne Diseases |
Q35869028 | Emerging infections in animals--potential new zoonoses? |
Q36312952 | Emerging infectious diseases: the Bunyaviridae |
Q56561007 | Environmental limits of Rift Valley fever revealed using ecoepidemiological mechanistic models |
Q34034096 | Epidemiologic and Clinical Aspects of a Rift Valley Fever Outbreak in Humans in Tanzania, 2007 |
Q40200902 | Epidemiological study of Rift Valley fever virus in Kigoma, Tanzania |
Q36300604 | Ethnic groups' knowledge, attitude and practices and Rift Valley fever exposure in Isiolo County of Kenya |
Q54251506 | Evaluation of Fluorescence Microsphere Immunoassay for the Detection of Antibodies to Rift Valley Fever Nucleocapsid Protein and Glycoproteins. |
Q35840989 | First External Quality Assessment of Molecular and Serological Detection of Rift Valley Fever in the Western Mediterranean Region |
Q38778411 | Generation of a Single-Cycle Replicable Rift Valley Fever Vaccine |
Q26314582 | Has Rift Valley fever virus evolved with increasing severity in human populations in East Africa? |
Q30230718 | Health risks at the Hajj |
Q21144476 | High content image-based screening of a protease inhibitor library reveals compounds broadly active against Rift Valley fever virus and other highly pathogenic RNA viruses |
Q91728993 | High seroconversion rate to Rift Valley fever virus in cattle and goats in far northern KwaZulu-Natal, South Africa, in the absence of reported outbreaks |
Q35363438 | High-content image-based screening of a signal transduction pathway inhibitor small-molecule library against highly pathogenic RNA viruses |
Q92081517 | Identification and evaluation of antivirals for Rift Valley fever virus |
Q36462318 | Identification of Rift Valley fever virus nucleocapsid protein-RNA binding inhibitors using a high-throughput screening assay |
Q39197757 | Identification of suitable areas for the occurrence of Rift Valley fever outbreaks in Spain using a multiple criteria decision framework |
Q33429285 | Inflammatory Biomarkers Associated with Lethal Rift Valley Fever Encephalitis in the Lewis Rat Model |
Q38677880 | Inter-epidemic Rift Valley fever virus seroconversions in an irrigation scheme in Bura, south-east Kenya |
Q37420463 | Inter-epidemic and between-season persistence of rift valley fever: vertical transmission or cryptic cycling? |
Q34952316 | Inter-epidemic transmission of Rift Valley fever in livestock in the Kilombero River Valley, Tanzania: a cross-sectional survey |
Q42928719 | Larvicidal Activities of Indigenous Bacillus thuringiensis Isolates and Nematode Symbiotic Bacterial Toxins against the Mosquito Vector, Culex pipiens (Diptera: Culicidae). |
Q35892951 | Lay perceptions of risk factors for Rift Valley fever in a pastoral community in northeastern Kenya |
Q42177525 | Mapping of major diseases and devising prevention and control regimen to common diseases in cattle and shoats in Dassenech district of South Omo Zone, South-Western Ethiopia |
Q34490520 | Mechanism of tripartite RNA genome packaging in Rift Valley fever virus |
Q30421040 | Modelling the effects of seasonality and socioeconomic impact on the transmission of rift valley Fever virus |
Q34660072 | Modelling vertical transmission in vector-borne diseases with applications to Rift Valley fever |
Q57017486 | Molecular Biology of Rift Valley Fever Virus~!2009-11-04~!2009-11-25~!2010-04-22~! |
Q33886954 | Molecular biology of rift valley Fever virus |
Q36291844 | Mosquito vectors survey in the AL-Ahsaa district of eastern Saudi Arabia |
Q40083734 | Mouse model for the Rift Valley fever virus MP12 strain infection. |
Q35024013 | NSm and 78-kilodalton proteins of Rift Valley fever virus are nonessential for viral replication in cell culture. |
Q36315241 | NSm protein of Rift Valley fever virus suppresses virus-induced apoptosis |
Q89996262 | NSs Filament Formation Is Important but Not Sufficient for RVFV Virulence In Vivo |
Q39195523 | NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase |
Q47144027 | Opinion of the Scientific Panel on Animal Health and Welfare (AHAW) on a request from the Commission related to “The Risk of a Rift Valley Fever Incursion and its Persistence within the Community” |
Q37567073 | Out of the bush: the Asian bush mosquito Aedes japonicus japonicus (Theobald, 1901) (Diptera, Culicidae) becomes invasive |
Q43167772 | Overlapping CD8+ and CD4+ T-cell epitopes identification for the progression of epitope-based peptide vaccine from nucleocapsid and glycoprotein of emerging Rift Valley fever virus using immunoinformatics approach. |
Q90695793 | Patterns of Rift Valley fever virus seropositivity in domestic ruminants in central South Africa four years after a large outbreak |
Q28469517 | Phylogeography of Rift Valley Fever Virus in Africa and the Arabian Peninsula |
Q28742390 | Planning for Rift Valley fever virus: use of geographical information systems to estimate the human health threat of white-tailed deer (Odocoileus virginianus)-related transmission |
Q34633660 | Population genetics of two key mosquito vectors of Rift Valley Fever virus reveals new insights into the changing disease outbreak patterns in Kenya |
Q36053652 | Potential effects of Rift Valley fever in the United States |
Q40346522 | Potential for North American Mosquitoes (Diptera: Culicidae) to Transmit Rift Valley Fever Virus |
Q40140711 | Potential for Psorophora columbiae and Psorophora ciliata Mosquitoes (Diptera: Culicidae) to Transmit Rift Valley Fever Virus |
Q30382776 | Public health. Pandemic H1N1 and the 2009 Hajj. |
Q35066405 | Public, environmental, and occupational health research activity in Arab countries: bibliometric, citation, and collaboration analysis |
Q60959433 | RVFV Infection in Goats by Different Routes of Inoculation |
Q27491320 | Rapid Accumulation of Virulent Rift Valley Fever Virus in Mice from an Attenuated Virus Carrying a Single Nucleotide Substitution in the M RNA |
Q34292066 | Recent outbreaks of rift valley Fever in East Africa and the middle East |
Q37513461 | Reemergence of Rift Valley fever, Mauritania, 2010. |
Q33570326 | Reverse genetics technology for Rift Valley fever virus: current and future applications for the development of therapeutics and vaccines |
Q33745109 | Reverse-phase phosphoproteome analysis of signaling pathways induced by Rift valley fever virus in human small airway epithelial cells |
Q35975309 | Rift Valley Fever Vaccine Virus Clone 13 Is Able to Cross the Ovine Placental Barrier Associated with Foetal Infections, Malformations, and Stillbirths |
Q27488329 | Rift Valley Fever, Mayotte, 2007–2008 |
Q41922817 | Rift Valley Fever: Does Wildlife Play a Role? |
Q42599665 | Rift Valley fever in goats, Cameroon |
Q40038707 | Rift Valley fever phlebovirus NSs protein core domain structure suggests molecular basis for nuclear filaments |
Q39251803 | Rift Valley fever vaccines: an overview of the safety and efficacy of the live-attenuated MP-12 vaccine candidate. |
Q26315215 | Rift Valley fever vector diversity and impact of meteorological and environmental factors on Culex pipiens dynamics in the Okavango Delta, Botswana |
Q40499504 | Rift Valley fever virus NSs mRNA is transcribed from an incoming anti-viral-sense S RNA segment |
Q36397378 | Rift Valley fever virus strain MP-12 enters mammalian host cells via caveola-mediated endocytosis |
Q36797004 | Rift Valley fever virus structural proteins: expression, characterization and assembly of recombinant proteins. |
Q33960690 | Rift Valley fever virus(Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention |
Q56917525 | Rift Valley fever: current challenges and future prospects |
Q33755025 | Rift valley fever virus nonstructural protein NSs promotes viral RNA replication and transcription in a minigenome system |
Q34174444 | Rift valley fever: recent insights into pathogenesis and prevention |
Q64288229 | Risk factors associated with sustained circulation of six zoonotic arboviruses: a systematic review for selection of surveillance sites in non-endemic areas |
Q28066283 | Safety and Efficacy Profile of Commercial Veterinary Vaccines against Rift Valley Fever: A Review Study |
Q40322035 | Safety and efficacy of Rift Valley fever Smithburn and Clone 13 vaccines in calves |
Q36085506 | Safety and immunogenecity of a live attenuated Rift Valley fever vaccine (CL13T) in camels |
Q64246621 | Safety and immunogenicity of Rift Valley fever MP-12 and arMP-12ΔNSm21/384 vaccine candidates in goats (Capra aegagrus hircus) from Tanzania |
Q91656354 | Safety and immunogenicity of a live attenuated Rift Valley Fever recombinant arMP-12ΔNSm21/384 vaccine candidate for sheep, goats and calves |
Q40075001 | Serological and genomic evidence of Rift Valley fever virus during inter-epidemic periods in Mauritania |
Q40153798 | Serological surveillance studies confirm the Rift Valley fever virus free status in South Korea |
Q29543293 | Seroprevalence of Alkhurma and Other Hemorrhagic Fever Viruses, Saudi Arabia |
Q57806005 | Seroprevalence of Rift Valley fever virus in cattle in the Democratic Republic of the Congo |
Q36337127 | Seroprevalence of Rift Valley fever virus in livestock during inter-epidemic period in Egypt, 2014/15. |
Q37067311 | Seroprevalence of Rift Valley fever virus in sheep and goats in Zambézia, Mozambique |
Q37433779 | Short Interfering RNA Inhibits Rift Valley Fever Virus Replication and Degradation of Protein Kinase R in Human Cells |
Q27488344 | Single-particle cryo-electron microscopy of Rift Valley fever virus |
Q37300854 | Socio-economic impact of Rift Valley fever to pastoralists and agro pastoralists in Arusha, Manyara and Morogoro regions in Tanzania |
Q27468611 | Spatial Heterogeneity of Habitat Suitability for Rift Valley Fever Occurrence in Tanzania: An Ecological Niche Modelling Approach |
Q35106416 | Spatial and temporal pattern of Rift Valley fever outbreaks in Tanzania; 1930 to 2007. |
Q30855605 | Spatial, seasonal and climatic predictive models of Rift Valley fever disease across Africa. |
Q38615473 | Structures of phlebovirus glycoprotein Gn and identification of a neutralizing antibody epitope |
Q27026883 | The 2007 Rift Valley fever outbreak in Sudan |
Q36506825 | The C-terminal region of Rift Valley fever virus NSm protein targets the protein to the mitochondrial outer membrane and exerts antiapoptotic function |
Q40174551 | The genetic basis for susceptibility to Rift Valley fever disease in MBT/Pas mice |
Q27311874 | The hexamer structure of Rift Valley fever virus nucleoprotein suggests a mechanism for its assembly into ribonucleoprotein complexes |
Q63246310 | The influence of raw milk exposures on Rift Valley fever virus transmission |
Q37433782 | The risk of Rift Valley fever virus introduction and establishment in the United States and European Union |
Q33195339 | Tropical dermatology: viral tropical diseases |
Q28079654 | Use of Aptamers as Diagnostics Tools and Antiviral Agents for Human Viruses |
Q34059387 | Uukuniemi Phlebovirus assembly and secretion leave a functional imprint on the virion glycome |
Q40399200 | Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus |
Q30234919 | Viral hemorrhagic fevers in the Tihamah region of the western Arabian Peninsula |
Q30389357 | Zoonoses in the Arabian Peninsula |
Q30987421 | Zoonotic risks from small ruminants |
Search more.